Medcomtech, S.A.
Simbolis: MED.MC
EURONEXT
0.69
EURRinkos kaina šiandien
0.0000
P/E santykis
0.0000
PEG koeficientas
8.92M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Medcomtech, S.A. (MED-MC) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1 | 1.6 | 1.8 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 9.4 | ||||||||||||||
balance-sheet.row.inventory | 0 | 7.4 | 6.3 | 6.1 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 19.5 | 19.1 | 17.3 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3.9 | 3.7 | 2.3 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.2 | 0.2 | 0.3 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.2 | 0.2 | 0.3 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 3.5 | 4 | 4.5 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 0.4 | 0.3 | 0 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 8.1 | 8.3 | 7.2 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 27.5 | 27.5 | 24.5 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 8.9 | 10.3 | 8 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1.1 | 1.3 | 1.1 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 4.6 | 3.1 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 3.6 | 3.8 | 2.3 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 13 | 9.3 | 9.2 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1.2 | 1.6 | 0 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 26.6 | 24.8 | 20.5 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1.6 | -1.3 | -1.8 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2.5 | 3.9 | 5.7 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1 | 2.7 | 4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 27.5 | 27.5 | 24.5 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 1 | 2.7 | 4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 3.6 | 4.1 | 4.6 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 5.1 | 5.9 | 4.2 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 4.1 | 4.4 | 2.5 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1.7 | -1.5 | -1.8 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1 | 0.9 | 0.8 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2.5 | 0.1 | -1.1 | ||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.inventory | 0 | -1.5 | -0.5 | -0.6 | ||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -1 | 0.7 | -0.6 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1.1 | 0.9 | 1.2 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1.2 | -2.4 | -1.5 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0.1 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.1 | -0.5 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0.1 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0.2 | -0.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1.2 | -2.3 | -1.9 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -1.3 | -0.1 | 0 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | 4 | 1.9 | 3.3 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.7 | 1.7 | 3.2 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -0.5 | -0.3 | 0.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1 | 1.5 | 1.7 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1.5 | 1.7 | 1.3 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -2 | 0.4 | -0.9 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -1.2 | -2.4 | -1.5 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | -3.2 | -2.1 | -2.4 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 22.4 | 20.2 | 18.6 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 7.5 | 8.2 | 7.4 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | 14.9 | 12 | 11.1 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | -0.2 | -0.3 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 14.1 | 11.4 | 11.3 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 21.6 | 19.6 | 18.7 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 0.5 | 0.4 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 1 | 1 | 1 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.2 | -1.1 | -1.6 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -0.2 | -0.3 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.2 | -1.1 | -1.6 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 1 | 1 | 1 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1 | 0.9 | 0.8 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | 0.3 | 0.2 | -0.2 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | -0.9 | -0.9 | -1.8 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -0.1 | -0.2 | 0 | ||||||||||||||
income-statement-row.row.net-income | 0 | -0.8 | -0.7 | -1.8 |
Dažnai užduodami klausimai
Kas yra Medcomtech, S.A. (MED.MC) bendras turtas?
Medcomtech, S.A. (MED.MC) bendras turtas yra 27533160.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.666.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.000.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.035.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.012.
Kas yra Medcomtech, S.A. (MED.MC) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra -778537.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 5101358.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 14101826.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.